Syndax Pharmaceuticals, Inc. 1T3.F Stock
Syndax Pharmaceuticals, Inc. Price Chart
Syndax Pharmaceuticals, Inc. 1T3.F Financial and Trading Overview
| Syndax Pharmaceuticals, Inc. stock price | 18.1 EUR |
| Previous Close | 19.7 EUR |
| Open | 19.1 EUR |
| Bid | 19.1 EUR x 80000 |
| Ask | 19.9 EUR x 80000 |
| Day's Range | 19.1 - 19.1 EUR |
| 52 Week Range | 14.8 - 26.4 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.38B EUR |
| Beta (5Y Monthly) | 1.129577 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.67 EUR |
1T3.F Valuation Measures
| Enterprise Value | 953.04M EUR |
| Trailing P/E | N/A |
| Forward P/E | -7.9916315 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.0040896 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.924 |
Trading Information
Syndax Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 1.129577 |
| 52-Week Change | 36.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.4 EUR |
| 52 Week Low | 14.8 EUR |
| 50-Day Moving Average | 18.75 EUR |
| 200-Day Moving Average | 21.83 EUR |
1T3.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 68.82M |
| Float | 58.34M |
| Short Ratio | N/A |
| % Held by Insiders | 4.18% |
| % Held by Institutions | 106.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.80% |
| Return on Equity (ttm) | -37.84% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -160888992 EUR |
| Net Income Avi to Common (ttm) | -153295008 EUR |
| Diluted EPS (ttm) | -2.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 438.2M EUR |
| Total Cash Per Share (mrq) | 6.37 EUR |
| Total Debt (mrq) | 1.06M EUR |
| Total Debt/Equity (mrq) | 0.24 EUR |
| Current Ratio (mrq) | 18.613 |
| Book Value Per Share (mrq) | 6.358 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -130972000 EUR |
| Levered Free Cash Flow (ttm) | -80895000 EUR |
Profile of Syndax Pharmaceuticals, Inc.
| Country | Germany |
| State | MA |
| City | Waltham |
| Address | 35 Gatehouse Drive |
| ZIP | 02451 |
| Phone | 781 419 1400 |
| Website | https://www.syndax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 107 |
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 for the treatment of KMT2A rearranged (KMT2Ar) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
Q&A For Syndax Pharmaceuticals, Inc. Stock
What is a current 1T3.F stock price?
Syndax Pharmaceuticals, Inc. 1T3.F stock price today per share is 18.1 EUR.
How to purchase Syndax Pharmaceuticals, Inc. stock?
You can buy 1T3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Syndax Pharmaceuticals, Inc.?
The stock symbol or ticker of Syndax Pharmaceuticals, Inc. is 1T3.F.
Which industry does the Syndax Pharmaceuticals, Inc. company belong to?
The Syndax Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Syndax Pharmaceuticals, Inc. have in circulation?
The max supply of Syndax Pharmaceuticals, Inc. shares is 85.8M.
What is Syndax Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Syndax Pharmaceuticals, Inc. PE Ratio is now.
What was Syndax Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Syndax Pharmaceuticals, Inc. EPS is -3.02 EUR over the trailing 12 months.
Which sector does the Syndax Pharmaceuticals, Inc. company belong to?
The Syndax Pharmaceuticals, Inc. sector is Healthcare.